Tradestie Institutional Equity Comparison Engine

ABVX vs USIN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVX Overall Edge

ABVX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Growth & Margin, Options & Structure while USIN counters with relative strength in Momentum & Technical. Fundamentally, ABVX trades at N/M Forward P/E with -6270.4% operating margin (-6.8% YoY revenue) versus USIN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against USIN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ABVX N/M vs USIN N/M Fwd P/E
Growth & Margin Winner ABVX
Op Margin -6270.4% vs N/A ยท YoY -6.8% vs N/A
Momentum & Technical Winner USIN
1Y -35.2% vs -5.5% ยท 52W Pos 12% vs 32%
Options & Structure Winner ABVX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$73.20
-9.24% 1D
Market Cap $7.1B
1M Return -18.87%
1Y Return -35.19%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 25.0 Fund 38.0 Flow 50.0 Mom 30.0
USIN US Equity
USIN
Institutional Equity
$48.19
+0.88% 1D
Market Cap N/A
1M Return +1.51%
1Y Return -5.54%
Forward P/E N/M
Unified AI Score
53.1 / 100 HOLD
Tech 67.0 Fund 63.0 Flow 50.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVX -35.19% USIN -5.54% Spread: +29.88 pp (USIN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVX TTM Op. Margin: -6270.4% USIN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs USIN. Trailing 12-month operating profitability (ABVX -6270.4% vs USIN N/A) and valuation multiples (ABVX N/M vs USIN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVX (5) vs USIN (3)
Institutional Metric ABVX USIN Criterion Row Winner
Market Capitalization Scale $7.1B N/A Larger Scale ABVX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -6.8% N/A Higher Growth ABVX
Operating Margin (TTM) Profitability -6270.4% N/A Higher Margin ABVX
Net Profit Margin Profitability 0.0% N/A Higher Margin ABVX
Return on Equity (ROE) Capital Efficiency -252.3% N/A Higher ROE ABVX
52-Week Range Position Momentum 12% ($63โ€“$149) 32% ($47โ€“$51) Stronger Trend USIN
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 55% Vol 0.08ฮฒ ยท 7% Vol Lower Realized Risk USIN
Unified Institutional Score Composite Signal 42.4 / 100 (HOLD) 53.1 / 100 (HOLD) Higher Composite USIN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVX vs USIN Buy Guide
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
USIN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live USIN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVX nor USIN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.